Search results :

Zidovudine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: J05AF01, S01AD05

Side effects

Options: Show MedDRA Preferred Terms,   display all 26 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Headache very common, 8.5% - 63% 37% - 53% x x x x x x x x x x x x x x x x x x x x
Malaise common, 8% - 55.6% 7% - 45% x x x x x x x x x x x x x x x x x x x x
Nausea rare — 7% - 61% 18% - 41% x x x x x x x x x x x x x x x x x x x x
Body temperature increased uncommon, 2.13% - 32% 12% x x x x x x x x x x x x x x x x x x x x
Anorexia rare, 6.38% - 20.1% 8% - 11% x x x x x x x x x x x x x x x x x x x x
Gastrointestinal pain 20% 19% x x x x x
Cough rare, 15% - 18% x x x x x x x x x x x x x x x x x x x x
Vomiting common, 2.13% - 25% 3% - 13% x x x x x x x x x x x x x x x x x x x x
Rash postmarketing — 12% - 17% 15% x x x x x x x x x x x x x x x x x x x x
Stomatitis 6% - 12% x x x x x x x x x x x x x
Hepatomegaly postmarketing — 11% x x x x x x x x x x x x x x x x x x x x
Rhinorrhoea 8% - 11% x x x x x x x x x x x x x
Asthenia uncommon, 8.6% - 9% 5.8% - 6% x x x x x x x x x x x x x x x x x x x x
Wheezing 7% - 9% x x x x x x x x x x x x x
Breath sounds abnormal 7% - 9% x x x x x x x x x x x x x
Lymphadenopathy postmarketing, 9% - 11% x x x x x x x x x x x x x x x x x x
Splenomegaly 5% - 8% x x x x x x x x x x x x x
Myalgia common, 8% 2% x x x x x x x x x x x x x x x x x x x x
Abdominal pain common, 8.51% - 21.3% x x x x x x x x x x x x x x x x x x x x
Constipation 6% - 8.1% 3.5% - 4% x x x x x x x x x x x x x x x x x x
Diarrhoea common, 6% - 14.9% 18% x x x x x x x x x x x x x x x x x x x x
Weight decreased 4.26% - 6.38% x x x x x x x x x x x x x x x x x x
Rigors 2.13% - 8.51% x x
Dyspepsia rare, 5% - 6% 1% - 4% x x x x x x x x x x x x x x x x x x x x
Sweating increased 5% 4% x x x x x
Hyperlactacidaemia common x x x x
Insomnia rare, 5% 1% x x x x x x x x x x x x x x x x x x x x
Neuropathy peripheral 4% - 25.5% x x x
Neutropenia common, 3% x x x x x x x x x x x x x x x x x x x x
Pharyngitis 2.1% - 8.51% x x x x x
Agranulocytosis 1.8% - 2% 1.6% - 2% x x x x x x x x x x x x x x x x x
Anaemia common, 1% - 2% 0.2% - 1% x x x x x x x x x x x x x x x x x x x x
Pain uncommon x x x x x x
Thrombocytopenia uncommon, 0% - 3% 0.5% - 1% x x x x x x x x x x x x x x x x x x x x
Lactic acidosis postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Amblyopia postmarketing x x x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x x x x x
Aplastic anaemia very rare, postmarketing x x x x x x x x x x x x x x x x x x
Haemolytic anaemia postmarketing x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x x
Anxiety postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Back pain postmarketing x x x x x x x x x x x x x x x x x x
Chest pain postmarketing — 2.13% - 6.38% x x x x x x x x x x x x x x x x x x x x
Confusional state postmarketing x x x x x x x x x x x x x x x x x x
Dysphagia postmarketing x x x x x x x x x x x x x x x x x x
Dizziness postmarketing — 6% - 20.8% 4% - 15.2% x x x x x x x x x x x x x x x x x x x x
Dysgeusia postmarketing — 5% 8% x x x x x x x x x x x x x x x x x x x x
Dyspnoea postmarketing — 5% 3% x x x x x x x x x x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x
Flatulence postmarketing, uncommon x x x x x x x x x x x x x x x x x x x x
Gynaecomastia postmarketing, rare x x x x x x x x x x x x x x x x
Hepatitis postmarketing x x x x x x x x x x x x x x x x x
Influenza rare x x x x x x x
Jaundice postmarketing x x x x x x x x x x x x x
Leukopenia postmarketing, common x x x x x x x x x x x x x x x x x x
Liver disorder rare x x x
Myopathy postmarketing, uncommon x x x x x x x x x x x x x x x x x x x x
Myositis postmarketing x x x x x x x x x x x x x x x x x
Pancreatitis postmarketing x x x x x x x x x x x x x x x x x x x x
Pancytopenia postmarketing, uncommon x x x x x x x x x x x x x x x x x x
Paraesthesia postmarketing — 6% 3% x x x x x x x x x x x x x x x x x x x x
Pruritus postmarketing, uncommon x x x x x x x x x x x x x x x x x x x x
Aplasia pure red cell postmarketing, rare x x x x x x x x x x x x x x x
Rhabdomyolysis postmarketing x x x x x x x x x x x x x
Rhinitis postmarketing x x x x x x x x x x x x x x x x x x
Convulsion postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Sinusitis postmarketing x x x x x x x x x x x x x x x x x x
Pigmentation skin rare x x
Muscle spasms postmarketing x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x
Sweating rare x x x x
Syncope postmarketing x x x x x x x x x x x x x x x x x x
Tremor postmarketing x x x x x x x x x x x x x x x x x x
Pollakiuria postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Urticaria postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Vasculitis postmarketing x x x x x x x x x x x x x x x x x
Vertigo postmarketing x x x x x x x x x x x x x x x x x x
Chills rare x x x x x x x x x x x x x x x x x x x x
Photophobia postmarketing x x x x x x x x x x x x x x x x x x
Mouth ulceration postmarketing, 4.26% - 27.7% x x x x x x x x x x x x x x x x x x
Lactic dehydrogenase activity increased postmarketing x x x x x x x x x x x x x
Bone marrow depression postmarketing, uncommon x x x x x x x x x x x x x x x x x x
Urinary hesitation postmarketing x x x x x x x x x x x x x x x x x x
Macular oedema postmarketing x x x x x x x x x x x x x x x x x
Generalized aching postmarketing x x x x x x x x x x x x x
Mania postmarketing x x x x x x x x x x x x x
Cardiomyopathy postmarketing, rare x x x x x x x x x x x x x x x x x x x x
Nail pigmentation postmarketing x x x x x x x x x x x x x x x x x x
Sensitisation postmarketing x x x x x x x x x x x x x x x x x x
Hearing impaired postmarketing x x x x x x x x x x x x x x x x x x
Mucosal pigmentation postmarketing, rare x x x x x x x x x x x x x x x x x
Somnolence postmarketing — 8% 9% x x x x x x x x x x x x x x x x x x x x
Abdominal cramps x x x x x x x x x x x x x
Congenital anomaly x
Acidosis x
Acquired immunodeficiency syndrome x x
Arthralgia x x x x x x x x x x x x x x x x x x
Bacteraemia x x x x
Mental disorder x x
Breast disorder x x
Connective tissue disorder x x
Cystitis x x x x
Dysuria x x x x x
Oedema x x x x x x x x x x x x x x x x x x
Epistaxis x x x x x
Eructation x x x x x
Fatigue x x x x x x x x x x x x x x x x
Gastrointestinal disorder x x
Gingival bleeding x x x x x
Cardiac disorder x x
Cardiac failure congestive x x x x x x x x x x x x x x x x x
Haematuria x x x x x x x x x x x x x x x x x
Hepatitis C x x x x x x x x x x
Hoarseness x x x x x
Hyperpathia x x x x x
Hyperbilirubinaemia x x x x x x x x x x x x x x x x x
Irritability x x x x x x x x x x x x x x x x x
Mediastinal disorder x x
Musculoskeletal pain x x x x x x x x x x x x x
Nervous system disorder x x
Nervousness x x x x x x x x x x x x x x x x x x
Night sweats x x x
Phlebitis x x x x
Polyuria x x x x x
Erythema x x x
Urinary tract disorder x x
Vasodilation x x x x x
Body odor x x x x x
Mood swings x x x x x
Generalised oedema x x x x
Tongue oedema x x x
Hyporeflexia x x x x x x x x x x x x x x x x x
Aspartate aminotransferase increased x
Skin discolouration x
Malnutrition x x x
Unspecified disorder of skin and subcutaneous tissue x x
Sickness x x x x x
Muscle twitching x x x x x
Rash erythematous x x x
Rash follicular x x x
Swollen tongue x x x
Oedema auricular x x x
Rectal haemorrhage x x x x x
Hepatobiliary disease x
Red cell aplasia x
Rash maculo-papular x x x
Neuropathy x x x x x x x x x x x x x
Auricular swelling x x x
Drug interaction x
Hypoxemia x
Acne x x x
Blood and lymphatic system disorders x x
Local reaction x x x
Fat redistribution x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ZIDOVUDINE / RETROVIR

Side effects:93
Source:FDA

Zidovudine

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

Zidovudine

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE

Side effects:94
Source:FDA Structured Product Label

Zidovudine

Side effects:94
Source:FDA Structured Product Label

ZIDOVUDINE / RETROVIR

Side effects:94
Source:FDA

ZIDOVUDINE / RETROVIR

Side effects:94
Source:FDA

zidovudine / RETROVIR

Side effects:97
Source:FDA

zidovudine / RETROVIR

Side effects:97
Source:FDA

ZIDOVUDINE / APO ZIDOVUDINE CAP 100MG

Side effects:107
Source:Health Canada

ZIDOVUDINE / RETROVIR (AZT)

Side effects:108
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label